Literature DB >> 22517601

Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.

Shimpei Nakatani1, Masami Nishino, Masayuki Taniike, Nobuhiko Makino, Hiroyasu Kato, Yasuyuki Egami, Ryu Shutta, Jun Tanouchi, Yoshio Yamada.   

Abstract

OBJECTIVES: We investigate the influence of stent design on stent coverage at 6-9 months after sirolimus eluting stent (SES) implantation using optical coherence tomography (OCT).
BACKGROUND: Although some reports suggest that stent design may correlate with stent coverage of stent struts, there were few detailed data whether stent design impact on stent coverage in the same drug-eluting stent.
METHODS: A total of 21 SESs (15 patients), who had implanted 2.5, 2.75, and 3.0 mm stents, underwent OCT at 6-9 months after stent implantation. SES is constructed by two different strut width-components; narrow strut width parts (59 μm) and wide strut width parts (115 μm). Thus, we divided stent struts of SESs into two groups: narrow strut width parts (narrow group) and wide ones (wide group). We compared the incidence of incomplete apposed struts, uncovered struts, and neointimal hyperplasia (NIH) thickness between the two groups.
RESULTS: We could detect 2,948 struts (narrow group consisted of 1,132 struts and wide group consisted of 1,816 struts). Incidence of uncovered struts in the narrow group was significantly lower than in the wide group (30.2% vs. 40.8%, P < 0.001), and NIH thickness in the narrow group was significantly greater than in the wide group (127.5 ± 93.4 μm vs. 118.6 ± 81.4 μm, P = 0.03).
CONCLUSIONS: Stent design, especially strut width, affects stent coverage of SES. The narrow strut may avoid the absence of stent coverage in SES, which correlates with stent thrombosis.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517601     DOI: 10.1002/ccd.24401

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  5 in total

1.  Comparable neointimal healing in patients with stable coronary lesions and acute coronary syndrome: 3-month optical coherence tomography analysis.

Authors:  Yuma Hamanaka; Yohei Sotomi; Tomoaki Kobayashi; Takashi Omatsu; Jouke Dijkstra; Yasushi Sakata; Atsushi Hirayama; Akio Hirata; Yoshiharu Higuchi
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-16       Impact factor: 2.357

2.  First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients.

Authors:  Eliano Pio Navarese; Mariusz Kowalewski; David Kandzari; Alexandra Lansky; Bartosz Górny; Lukasz Kołtowski; Ron Waksman; Sergio Berti; Giuseppe Musumeci; Ugo Limbruno; Rene J van der Schaaf; Malte Kelm; Jacek Kubica; Harry Suryapranata
Journal:  Open Heart       Date:  2014-08-21

3.  Design optimization of stent and its dilatation balloon using kriging surrogate model.

Authors:  Hongxia Li; Tao Liu; Minjie Wang; Danyang Zhao; Aike Qiao; Xue Wang; Junfeng Gu; Zheng Li; Bao Zhu
Journal:  Biomed Eng Online       Date:  2017-01-11       Impact factor: 2.819

4.  Long-term safety and absorption assessment of a novel bioresorbable nitrided iron scaffold in porcine coronary artery.

Authors:  Jian-Feng Zheng; Zi-Wei Xi; Yang Li; Jia-Nan Li; Hong Qiu; Xiao-Ying Hu; Tong Luo; Chao Wu; Xin Wang; Lai-Feng Song; Li Li; Hai-Ping Qi; Gui Zhang; Li Qin; Wan-Qian Zhang; Xiao-Li Shi; Shu-Han Wang; De-Yuan Zhang; Bo Xu; Run-Lin Gao
Journal:  Bioact Mater       Date:  2022-01-11

5.  Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

Authors:  Eliano P Navarese; Kenneth Tandjung; Bimmer Claessen; Felicita Andreotti; Mariusz Kowalewski; David E Kandzari; Dean J Kereiakes; Ron Waksman; Laura Mauri; Ian T Meredith; Aloke V Finn; Hyo-Soo Kim; Jacek Kubica; Harry Suryapranata; Toni Mustahsani Aprami; Giuseppe Di Pasquale; Clemens von Birgelen; Elvin Kedhi
Journal:  BMJ       Date:  2013-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.